BIO announces presenting companies for annual conference.

Press Release Summary:



BIO announced preliminary list of presenting companies for the 16th Annual BIO CEO & Investor Conference to be held Feb 10-11, 2014 in New York City. Presenting companies are hand-selected for event, and consist of mid- to large-cap established public as well as late-stage private companies worldwide. Companies typically have a clinical stage program centered around therapeutics, molecular diagnostics, or a platform technology, as well as upcoming clinical, regulatory, or corporate catalyst.



Original Press Release:



BIO Announces Presenting Companies for 16th Annual BIO CEO and Investor Conference



More than 140 Companies Expected to Present Their Story to Top Public and Venture Capital Investors



WASHINGTON--The Biotechnology Industry Organization (BIO) today announced the preliminary list of presenting companies for the 16th Annual BIO CEO & Investor Conference to be held February 10-11, 2014 in New York City. Presenting companies are hand-selected for the event, and consist of a selection of mid- to large-cap established public as well as late-stage private companies from around the globe. These companies typically have a clinical stage program centered around therapeutics, molecular diagnostics or a platform technology, as well as an upcoming clinical, regulatory or corporate catalyst.



“2013 has been a banner year for the biotech sector. We have seen more than 40 biotech IPOs this year alone, 15 of which will be represented through company presentations”



“2013 has been a banner year for the biotech sector. We have seen more than 40 biotech IPOs this year alone, 15 of which will be represented through company presentations,” said BIO president & CEO Jim Greenwood. “The BIO CEO and Investor Conference will allow investors and companies alike to engage amongst their peers and discover how best to take advantage of the current market opportunities for the year ahead.”



The following companies are slated to present at this year’s conference:



Public Companies:



ACADIA Pharmaceuticals

AcelRx Pharmaceuticals

Advanced Cell Technology

Advaxis

Agenus

Alcobra Ltd.

Alexion Pharmaceuticals

Alkermes plc

Allergan

Alnylam Pharmaceuticals

Amarantus Bioscience

Anavex Life Sciences Corp.

Anthera Pharmaceuticals

AntriaBio

Apricus Biosciences

Aradigm Corp.

Arena Pharmaceuticals

Athersys

Auxilium Pharmaceuticals

Avita Medical

Bavarian Nordic A/S

BIND Therapeutics*

Biodel

BioLineRx

Biotie Therapies

Catalyst Pharmaceutical Partners

CEL-SCI Corporation

Cempra

Chimerix*

Cleveland BioLabs

Codexis

Columbia Laboratories

Conatus Pharmaceuticals*

Cyclacel Pharmaceuticals

CytoDyn

Cytokinetics

CytRx Corporation

DARA BioSciences

DURECT Corporation

Epizyme*

Exelixis

FivePrime Therapeutics*

Galectin Therapeutic

Galena Biopharma

GENFIT

GenSpera

GTx

Heat Biologics*

Horizon Pharma

Idera Pharmaceuticals

Ignyta

ImmunoCellular Therapeutics

Immunovaccine

Innovus Pharmaceuticals

Inovio Pharmaceuticals

Intra-Cellular Therapies

Intrexon Corporation*

KaloBios Pharmaceuticals*

Keryx Biopharmaceuticals

La Jolla Pharmaceutical Company

Lexicon Pharmaceuticals

Lpath

Mast Therapeutics

Medigene AG

Merck Serono

Mesoblast

Navidea Biopharmaceuticals

NeoStem

Neuralstem

Newron Pharmaceuticals S.p.A.

Northwest Biotherapeutics

NovaBay Pharmaceuticals

Novelos Therapeutics

OHR Pharmaceutical

OncoMed Pharmaceuticals*

Onconova Therapeutics*

OncoSec Medical

Opexa Therapeutics

Ophthotech*

Oragenics

Orexigen Therapeutics

OvaScience

OXiGENE

PDL BioPharma

Prima BioMed

Prometic LifeSciences

Prosensa

pSiVida

Regado Biosciences*

Relypsa*

ReNeuron Group plc

Repros Therapeutics

Resverlogix

Rexahn Pharmaeuticals

Rigel Pharmaceuticals

RXi Pharmaceuticals

Sanofi

SciClone Pharmaceuticals

Selvita S.A.

SIGA Technologies

Soligenix

Sorrento Therapeutics

Stallergenes

Stem Cell Therapeutics

StemCells Inc.

Stemline Therapeutics*

Swedish Orphan Biovitrum AB

SYGNIS AG

Synergy Pharmaceuticals

Synthetic Biologics

Targacept

Tekmira Pharmaceuticals Corporation

Tetraphase Pharmaceuticals*

TG Therapeutics

The Medicines Company

TiGenix N.V.

Tonix Pharmaceuticals

Transition Therapeutics

TrovaGene

Verastem

ZIOPHARM Oncology



Private Companies:



Aduro Biotech

ALS Therapy Development Institute

Cerecor

CymaBay

Kadmon Corporation

KineMed

MaxCyte

Melinta Therapeutics

Mirna Therapeutics

Pieris AG

Polynoma

Proteon Therapeutics

Q Therapeutics

Sutro Biopharma

Symphogen

Trevena

TxCell SA

XDx

*indicates 2013 IPO



Check back often as new presenters are continuously being added. Companies interested in presenting their story can submit an application here.



In addition to Company Presentations, the conference will host Fireside Chats, Therapeutic Workshops, Business Roundtables and the opportunity to arrange meetings between investors, companies and industry executives via BIO’s One-on-One Partnering™ System.



Qualified institutional and venture investors whose primary activity is direct investment in research and development companies are eligible for complimentary registration. Equity research analysts from investment banking institutions also qualify as investors. Media registration also is complimentary for credentialed members of the media. All registrations are subject to verification of credentials.



BIO is pleased to recognize the leadership provided by the BIO CEO & Investor Conference sponsors including supporting banks Leerink Swann and ROTH Capital Partners, LLC.



About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.



Upcoming BIO Events



BIO CEO & Investor Conference

February 10–11, 2014

New York, NY



BIO Asia International Conference

April 8-9, 2014

Tokyo, Japan



World Congress on Industrial Biotechnology

May 12-15, 2014

Philadelphia, PA



BIO International Convention

June 23-26, 2014

San Diego, CA



Livestock Biotech Summit

September 16-18, 2014

Sioux Falls, SD



Contacts

Biotechnology Industry Organization (BIO)

Abigail Hirsch, 1-202-962-9235

ahirsch@bio.org

Web: www.bio.org

Blog: www.biotech-now.org

Twitter: @IAmBiotech


All Topics